Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue

Aim: To study the efficacy of autovaccine in the treatment of gastric cancer and significance of molecular factors having prognostic values for disease outcome to evaluate its efficacy in clinical setting. Patients and Methods: 150 patients with histologically proven adenocarcinoma of the stomach of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2009
Hauptverfasser: Bazas, V.M., Lukyanova, N.Yu., Lisovenko, G.S., Rozumiy, D.O., Potebnya, G.P.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/138135
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue / V.M. Bazas, N.Yu. Lukyanova, G.S. Lisovenko, D.O. Rozumiy, G.P. Potebnya // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 182-184. — Бібліогр.: 18 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-138135
record_format dspace
spelling Bazas, V.M.
Lukyanova, N.Yu.
Lisovenko, G.S.
Rozumiy, D.O.
Potebnya, G.P.
2018-06-18T09:39:30Z
2018-06-18T09:39:30Z
2009
Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue / V.M. Bazas, N.Yu. Lukyanova, G.S. Lisovenko, D.O. Rozumiy, G.P. Potebnya // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 182-184. — Бібліогр.: 18 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/138135
Aim: To study the efficacy of autovaccine in the treatment of gastric cancer and significance of molecular factors having prognostic values for disease outcome to evaluate its efficacy in clinical setting. Patients and Methods: 150 patients with histologically proven adenocarcinoma of the stomach of stages II, III or IV were enrolled into study. 86 patients have been treated with autovaccine (AV) after operation. Expression of p53, Bcl-2, receptors of tyrosine kinase, vascular endothelial growth factor (VEGF), Е-cadherin, α-catenin and β-catenin was determined in paraffin embedded tumor samples by means of immunohistochemical method with the use of respective monoclonal antibodies. Results: It was shown that application of AV has resulted in the increase of 3-year overall survival of patients having stage III of disease by more than 30%, but those having stage IV — only around 14%. The increase of 3-year overall survival of patients with metastases in lymph nodes (N1–2) was observed also in more than 30%. It has been suggested the optimal phenotype for vaccine application: р53(+), EGFR(+), HER-2 neu (+), β-catenin (+), VEGF(+) and Bcl-2(+) with no dependence on E-cadherin and α-catenin presence. Conclusion: It was determined that the best effect of AV application is observed in patients with category Т3–4, poorly-differentiated tumors, metastases in lymph nodes (N1–2), but without distant metastases (М0). Gastric cancer patients with p53, EGFR, HER-2/neu, β-catenin, VEGF and Bcl-2-positive tumors are the favorable group for the treatment with AV in the adjuvant regime.
Authors thank Dr. L.N. Bubnovskaya, Ph.D. for her helpful assistance.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Short communications
Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
spellingShingle Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
Bazas, V.M.
Lukyanova, N.Yu.
Lisovenko, G.S.
Rozumiy, D.O.
Potebnya, G.P.
Short communications
title_short Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
title_full Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
title_fullStr Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
title_full_unstemmed Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
title_sort postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
author Bazas, V.M.
Lukyanova, N.Yu.
Lisovenko, G.S.
Rozumiy, D.O.
Potebnya, G.P.
author_facet Bazas, V.M.
Lukyanova, N.Yu.
Lisovenko, G.S.
Rozumiy, D.O.
Potebnya, G.P.
topic Short communications
topic_facet Short communications
publishDate 2009
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Aim: To study the efficacy of autovaccine in the treatment of gastric cancer and significance of molecular factors having prognostic values for disease outcome to evaluate its efficacy in clinical setting. Patients and Methods: 150 patients with histologically proven adenocarcinoma of the stomach of stages II, III or IV were enrolled into study. 86 patients have been treated with autovaccine (AV) after operation. Expression of p53, Bcl-2, receptors of tyrosine kinase, vascular endothelial growth factor (VEGF), Е-cadherin, α-catenin and β-catenin was determined in paraffin embedded tumor samples by means of immunohistochemical method with the use of respective monoclonal antibodies. Results: It was shown that application of AV has resulted in the increase of 3-year overall survival of patients having stage III of disease by more than 30%, but those having stage IV — only around 14%. The increase of 3-year overall survival of patients with metastases in lymph nodes (N1–2) was observed also in more than 30%. It has been suggested the optimal phenotype for vaccine application: р53(+), EGFR(+), HER-2 neu (+), β-catenin (+), VEGF(+) and Bcl-2(+) with no dependence on E-cadherin and α-catenin presence. Conclusion: It was determined that the best effect of AV application is observed in patients with category Т3–4, poorly-differentiated tumors, metastases in lymph nodes (N1–2), but without distant metastases (М0). Gastric cancer patients with p53, EGFR, HER-2/neu, β-catenin, VEGF and Bcl-2-positive tumors are the favorable group for the treatment with AV in the adjuvant regime.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/138135
citation_txt Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue / V.M. Bazas, N.Yu. Lukyanova, G.S. Lisovenko, D.O. Rozumiy, G.P. Potebnya // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 182-184. — Бібліогр.: 18 назв. — англ.
work_keys_str_mv AT bazasvm postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue
AT lukyanovanyu postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue
AT lisovenkogs postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue
AT rozumiydo postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue
AT potebnyagp postoperativeautovaccinotherapyforpatientswithgastriccancerandexpressionofsomeproteinsintumortissue
first_indexed 2025-11-29T07:12:39Z
last_indexed 2025-11-29T07:12:39Z
_version_ 1850854629134303232